Virginia Tech® home

In Person Seminar: Pathogenic Mechanisms and Novel Therapies for Immune Neoplasms

Insert your title here

Ari Melnick, M.D.

Gebroe Family Professor of Hematology/Oncology
Department of Medicine
Director, Sackler Center for Biomedical and Physical Sciences
Weill Medical College
Cornell University

Pioneers in Biomedical Research Seminar: Pathogenic Mechanisms and Novel Therapies for Immune Neoplasms 

Date: Feb. 10, 2023

Time: 11 a.m. - 12 p.m.

About this Seminar

A majority of hematologic malignancies arise from B-cells undergoing the adaptive immune response.  Dr. Melnick will discuss recent insights explaining why this particular pathway is so prone to transformation and how B-cells arise from aberrant immune niches.  He will also discuss some of the therapeutic vulnerabilities discovered based on mechanistic observations of the pathogenic trajectory of these tumors.

Additional Details

This is a free event hosted by the Fralin Biomedical Research Institute and co-sponsored by the institute's Cancer Research Group. The Pioneers in Biomedical Research Seminar Series, which runs annually from September to May, has featured leading biomedical researchers from throughout the country since the program began in 2012. The lectures are also open to all members of the Virginia Tech community including graduate students, undergraduates, faculty, and staff, as well as the public.

You May Also Be Interested In...